Filter
2442
Filtered Results: 2442
Text search:
mass
drug
Featured
Recommendations
235
New Publications
689
Language
Document type
No document type
1432
Studies & Reports
399
Guidelines
291
Manuals
118
Strategic & Response Plan
118
Training Material
31
Fact sheets
30
Infographics
9
Situation Updates
8
Brochures
2
Resource Platforms
2
Online Courses
2
Countries / Regions
India
163
Global
110
Kenya
77
Ethiopia
72
Uganda
64
Nepal
50
South Africa
50
Sierra Leone
49
Western and Central Europe
48
Zambia
48
Liberia
48
Nigeria
46
Rwanda
45
Bangladesh
43
Malawi
41
Ghana
40
Tanzania
40
Philippines
34
Myanmar / Burma
33
Ukraine
31
Africa
29
Latin America and the Carribbean
26
Namibia
26
Cambodia
21
Eastern Europe
21
Syria
20
Zimbabwe
19
South–East Asia Region
19
Mozambique
18
Congo, Democratic Republic of
18
Indonesia
18
West and Central Africa
17
Senegal
16
Lesotho
14
Asia
14
East and Southern Africa
14
South Sudan
13
Eswatini/ Swaziland
12
Russia
11
Botswana
11
Burkina Faso
9
Haiti
9
Middle East and North Africa
9
Brazil
9
Guinea
7
Afghanistan
6
USA
6
Venezuela
6
Germany
6
Eastern Europe and Central Asia
6
Pakistan
6
Thailand
5
Cameroon
5
Western Pacific Region
5
Sudan
5
Yemen
5
Somalia
5
Tajikistan
4
Iran
4
Laos
4
Peru
4
North America
4
United Kingdom
4
Vietnam
4
Madagascar
4
Colombia
3
Timor Leste/ East Timor
3
El Salvador
3
Turkey
3
Burundi
3
Jordan
3
Lebanon
3
Sri Lanka
3
Georgia
3
Central African Republic
3
Bhutan
3
Iraq
3
Mexico
2
China
2
Chile
2
Albania
2
Saudi Arabia
2
Southern Africa
2
Bolivia
2
Argentina
2
Papua New Guinea
2
Mali
2
Libya
2
North Macedonia
1
North Korea
1
Benin
1
Gambia
1
Kazakhstan
1
Canada
1
Singapore
1
Estonia
1
Kyrgyzstan
1
Niger
1
Morocco
1
Mongolia
1
Armenia
1
Lithuania
1
Paraguay
1
Turkmenistan
1
France
1
Mauritius
1
Tunisia
1
Portugal
1
Spain
1
Azerbaijan
1
Belarus
1
Latvia
1
Moldova
1
Djibouti
1
Egypt
1
Greece
1
Palestine
1
Poland
1
Honduras
1
Angola
1
Chad
1
Ecuador
1
Authors & Publishers
Publication Years
Category
Countries
1090
Clinical Guidelines
235
Public Health
170
Women & Child Health
89
Key Resources
69
Capacity Building
35
Pharmacy & Technologies
20
Annual Report MEDBOX
1
Toolboxes
COVID-19
152
HIV
144
Mental Health
140
TB
140
NTDs
139
NCDs
84
Rapid Response
78
AMR
71
Conflict
54
Pharmacy
52
Planetary Health
49
Caregiver
45
Refugee
36
Ebola
36
Global Health Education
28
Natural Hazards
25
Disability
17
Cholera
17
Specific Hazards
14
Zika
11
Health Financing Toolbox
10
Social Ethics
7
Polio
4
South Sudan
1
Guideline ‒ Alternative mass drug administration regimens to eliminate lymphatic filariasis
recommended
Lymphatic filariasis is a vector-borne neglected tropical disease that causes damage of the lymphatic system and can lead to lymphoedema (elephantiasis) and hydrocele in infected individuals. The global baseline estimate of persons affected by lymphatic filariasis is 25 million men with hydrocele an...
Countries, partners, and donors are committed to
the global elimination of blinding trachoma by 2020.
Achieving this public health milestone requires more
than funding; it requires health personnel with the
right mix of skills, and well supported and managed
health systems. Mass drug administra...
Following the publication of Guidelines on certification of elimination of human onchocerciasis in 2001 by the World Health Organization (WHO), these are the first evidence-based guidelines developed by NTD Department according to the international standards.
Following the publication of Guidelines on certification of elimination of human onchocerciasis in 2001 by the World Health Organization (WHO), these are the first evidence-based guidelines developed by NTD Department according to the international standards. They provide a set of recommendations th...
Training in monitoring and epidemiological assessment of mass drug administration for eliminating lymphatic filariasis: learners’ guide. World Health Organization.
Background: Despite several cycles of Mass Drug Administration (MDA), however, the prevalence of Soil-transmitted helminthiasis (STH) remains high in Bangladesh. A clear understanding of local knowledge, attitudes, and practices (KAP) related to the acceptance and utilization of MDA is critical for ...
Effective monitoring, epidemiological assessment and evaluation are necessary to achieve the aim of interrupting LF transmission. This manual is designed to ensure that national elimination programmes have available the best information on methodologies and procedures for monitoring MDA, appropriate...
Many countries have made significant progress in the implementation of World Health Organization recommended preventive chemotherapy strategy, to eliminate lymphatic filariasis (LF). However, pertinent challenges such as the existence of areas of residual infections in disease endemic districts pose...
Soil-transmitted helminths (STH) affect 1.45 billion people worldwide, and high intensity infections are associated with anemia, undernutrition and impaired cognition, particularly among children. Mathematical models suggest it may be possible to interrupt the transmission of STH in a community by e...
The Global Programme to Eliminate Lymphatic Filariasis (LF) is using mass drug administration (MDA) of antifilarial medications to treat filarial infections, prevent disease and interrupt transmission. Almost 500 million people receive these medications each year. Clinical trials have recently shown...
Soil transmitted helminth (STH) infections are among the most common human infections worldwide with over 1 billion people affected. Many estimates of STH infection are often based on school-aged children (SAC). This study produced predictive risk-maps of STH on a more finite scale, estimated the nu...
To support its R&D activities on Chagas disease, DNDi launched the Chagas Clinical Research Platform (CCRP). The platform brings together partners, experts, and stakeholders to provide support for evaluation and development of new treatments for Chagas disease. The patient-centred platform aims to f...
Better drug regimens for mass drug administration (MDA) could accelerate the Global Programme to Eliminate Lymphatic Filariasis (LF). This community study was designed to compare the safety and efficacy of MDA with IDA (ivermectin, diethylcarbamazine and albendazole) or DA (diethylcarbamazine and ...
A key component of achieving control and elimination of neglected tropical diseases (NTDs) is effective supply chain management of preventive chemotherapy drugs for Mass Drug Administration (MDA) for trachoma, river blindness, lymphatic filariasis, soil-transmitted helminthiasis and schistosomiasis....
Yaws is targeted for eradication by 2030, using a strategy based on mass drug administration (MDA) with azithromycin. New diagnostics are needed to aid eradication. Serology is currently the mainstay for yaws diagnosis; however, inaccuracies associated with current serological tests makes it difficu...
This manual summarizes key issues related to the safety of NTD medicines and their administration, with a focus on essential medicines used in mass drug administration (MDA), also called preventive chemotherapy. It can be used as a standalone reference manual, but is intended to be used in conjuncti...
Lymphatic filariasis is a neglected tropical disease that can cause permanent disability through disruption of the lymphatic system. This disease is caused by parasitic filarial worms that are transmitted by mosquitos. Mass drug administration (MDA) of antihelmintics is recommended by WHO to elimina...
To eliminate lymphatic filariasis (LF) by 2020, the World Health Organization (WHO) has launched a campaign against the disease. Since the launch in 2000, significant progress has been made to achieve this ambitious goal. In this article we review the progress and status of the LF programme in Afric...
The control and elimination of schistosomiasis have over the last two decades involved several strategies, with the current strategy by the World Health Organization (WHO) focusing mainly on treatment with praziquantel during mass drug administration (MDA). However, the disease context is complex wi...
